Kenvue (KVUE) is mulling the sale of some of its skin health and beauty brands as the management looks to prune some of its underperforming business assets to focus on core products, Reuters reports, citing people familiar with the matter. Kenvue plans to hold onto the bigger names, such as Neutrogena and Aveeno, the report states.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
Disclaimer & DisclosureReport an Issue